Minnesota Oncology Hematology, PA — Edina, Minnesota

Minnesota Oncology Hematology, PA is a clinical research site located in Edina, Minnesota, United States 55435.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology, PA has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Colorectal Neoplasms, Newly Diagnosed.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, AstraZeneca.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology, PA?

Minnesota Oncology Hematology, PA has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology, PA conducted?

Minnesota Oncology Hematology, PA has 3 clinical trials on record, with 2 currently active. Their work covers Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Colorectal Neoplasms, Newly Diagnosed.

Is Minnesota Oncology Hematology, PA accredited by Crixeo Health?

Minnesota Oncology Hematology, PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Oncology Hematology, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.